Merck Invests Approximately € 70 Million to Expand Reagent Manufacturing in China

Adds production capacity to further provide customers with highly purified reagents for quality control and testing Major investment at company’s ...

July 04, 2023 | Tuesday | News
Bruker Introduces SciY™ Platform for Digital Transformation in Life Science and Biopharma

SciY is being launched by Bruker’s new Integrated Data Solutions division, in close collaboration with majority-owned software companies Mestrelab Re...

July 03, 2023 | Monday | News
Sandoz Launches Hyrimoz® High-Concentration Formulation in US Immunology Space

Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) biosimilar offers US patients reduced injection volume in citrate-free formulation A...

July 03, 2023 | Monday | News
Thermo Fisher Scientific Launches Cancer Treatment-Enabling Tumor Culture Medium

Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...

June 29, 2023 | Thursday | News
TLX250-CDx Shows Potential Utility in ccRCC Staging: New ZIRCON Phase III Data Presented in Australia.

New data demonstrates the ability of TLX250-CDx to detect extrarenal lesions, supporting potential clinical utility in the metastatic or recurrent setting,...

June 27, 2023 | Tuesday | News
Enveric Biosciences Advances EB-373 with Phase 1 Formulation and Manufacturing Initiation.

Enveric to expand existing manufacturing agreement with CDMO partner for enhanced supply of non-GMP and GMP EB-373 drug substance Enveric Biosciences (NAS...

June 27, 2023 | Tuesday | News
Twist Bioscience Publishes Preclinical Data Validating GLP-1R Antagonist Antibody for Congenital Hyperinsulinism Treatment.

-Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

June 27, 2023 | Tuesday | News
Bristol Myers Squibb Gets European Commission Approval for CAMZYOS® in Treating Symptomatic Obstructive HCM

CAMZYOS is the first and only cardiac myosin inhibitor approved in the European Union Approval based on two positive Phase 3 trials, EXPLORER-HCM and VALO...

June 27, 2023 | Tuesday | News
Kite Successfully Transfers Marketing Authorization for Yescarta® CAR T-cell Therapy in Japan

- Gilead Sciences K.K. is Now Marketing Authorization Holder -- -- Kite Cell Therapy Business Unit of Gilead Sciences K.K. will manage the product’s...

June 23, 2023 | Friday | News
South Korean SK pharmteco doubles viral vector production capacity in Europe

Yposkesi, SK pharmteco's clinical and commercial viral vector manufacturing subsidiary for Cell and Gene Therapy (C>), completes i...

June 23, 2023 | Friday | News
Cytiva launches 2023 Biopharma Resilience Index

Biopharma’s own leaders express a declining sense of industry resilience in the latest wide-reaching survey from Cytiva. The Global Biopharma Resilie...

June 22, 2023 | Thursday | Reports
Dyadic Partners with Bangladesh's State-Owned Pharma for Biopharmaceutical Research and Manufacturing

“We are pleased to announce this strategic partnership with the government of Bangladesh, which demonstrates the company’s continued ability to...

June 22, 2023 | Thursday | News
Navidea Biopharmaceuticals, Inc. Gets $7.5M Cash from Cardinal Health Instead of Milestone Payment

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precis...

June 20, 2023 | Tuesday | News
FDA Approves Roche's Columvi: Groundbreaking Fixed-Duration Treatment for Diffuse Large B-cell Lymphoma

Pivotal study showed durable responses, with a 56% overall response rate, a 43% complete response (remission) rate and a median duration of response of 1...

June 19, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close